Yujun Long

471 total citations
24 papers, 283 citations indexed

About

Yujun Long is a scholar working on Psychiatry and Mental health, Physiology and Molecular Biology. According to data from OpenAlex, Yujun Long has authored 24 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 7 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Yujun Long's work include Schizophrenia research and treatment (12 papers), Diet and metabolism studies (7 papers) and Tryptophan and brain disorders (5 papers). Yujun Long is often cited by papers focused on Schizophrenia research and treatment (12 papers), Diet and metabolism studies (7 papers) and Tryptophan and brain disorders (5 papers). Yujun Long collaborates with scholars based in China, United States and Sweden. Yujun Long's co-authors include Renrong Wu, Jingping Zhao, Jingmei Xiao, Ye Yang, Chenchen Liu, Ye Yang, Gangrui Hei, Jing Huang, Xiaoyi Wang and Jingping Zhao and has published in prestigious journals such as Gut, Schizophrenia Bulletin and Psychopharmacology.

In The Last Decade

Yujun Long

22 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yujun Long China 10 98 92 89 79 45 24 283
Berko Milleit Germany 11 100 1.0× 123 1.3× 103 1.2× 78 1.0× 34 0.8× 14 357
Helena Kyunghee Kim Canada 9 119 1.2× 144 1.6× 132 1.5× 41 0.5× 20 0.4× 12 365
Sayna Bagheri Iran 11 82 0.8× 57 0.6× 52 0.6× 40 0.5× 38 0.8× 21 239
Thaddeus K. Weigel United States 6 81 0.8× 175 1.9× 25 0.3× 52 0.7× 34 0.8× 8 382
Mengjia Pu China 10 90 0.9× 84 0.9× 59 0.7× 39 0.5× 41 0.9× 16 342
Albert Orock United States 12 115 1.2× 29 0.3× 23 0.3× 97 1.2× 24 0.5× 17 313
Edemilson Mariot Brazil 10 121 1.2× 107 1.2× 153 1.7× 62 0.8× 28 0.6× 12 357
Bjørn‐Eivind Kirsebom Norway 9 94 1.0× 54 0.6× 172 1.9× 231 2.9× 75 1.7× 40 451
Joshua Crawford United States 10 94 1.0× 28 0.3× 43 0.5× 130 1.6× 26 0.6× 17 320
Jesús‐Servando Medel‐Matus United States 13 137 1.4× 26 0.3× 149 1.7× 88 1.1× 38 0.8× 22 383

Countries citing papers authored by Yujun Long

Since Specialization
Citations

This map shows the geographic impact of Yujun Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujun Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujun Long more than expected).

Fields of papers citing papers by Yujun Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujun Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujun Long. The network helps show where Yujun Long may publish in the future.

Co-authorship network of co-authors of Yujun Long

This figure shows the co-authorship network connecting the top 25 collaborators of Yujun Long. A scholar is included among the top collaborators of Yujun Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujun Long. Yujun Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Long, Yujun, Jingmei Xiao, Ying Wang, et al.. (2025). A comprehensive metabolomic and lipidomic study of olanzapine in the treatment of first-episode schizophrenia. Asian Journal of Psychiatry. 105. 104387–104387. 1 indexed citations
3.
Huang, Yating, Zhirong Yang, Yujun Long, et al.. (2025). Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts. Gut. 75(4). 772–785. 3 indexed citations
5.
Xie, Peng, Yujun Long, Ye Yang, et al.. (2024). Orlistat for the treatment of antipsychotic-induced weight gain: an eight-week multicenter, randomized, placebo-controlled, double-blind trial. Lipids in Health and Disease. 23(1). 225–225. 1 indexed citations
6.
Hei, Gangrui, Yujun Long, Jingmei Xiao, et al.. (2024). Exploring the latent cognitive structure in schizophrenia: implications for antipsychotic treatment responses. European Archives of Psychiatry and Clinical Neuroscience. 275(3). 691–699.
8.
Long, Yujun, Yidong Shen, Jing Huang, et al.. (2023). Minocycline and antipsychotics inhibit inflammatory responses in BV-2 microglia activated by LPS via regulating the MAPKs/ JAK-STAT signaling pathway. BMC Psychiatry. 23(1). 514–514. 28 indexed citations
9.
Huang, Jing, Chenchen Liu, Ye Yang, et al.. (2022). The effects of probiotics plus dietary fiber on antipsychotic-induced weight gain: a randomized clinical trial. Translational Psychiatry. 12(1). 185–185. 23 indexed citations
10.
Yang, Ye, Peng Xie, Yujun Long, et al.. (2022). Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments. BMC Psychiatry. 22(1). 210–210. 3 indexed citations
11.
Huang, Yuyan, Gangrui Hei, Ye Yang, et al.. (2022). Altered regional homogeneity and cognitive impairments in first-episode schizophrenia: A resting-state fMRI study. Asian Journal of Psychiatry. 71. 103055–103055. 24 indexed citations
12.
Huang, Jing, Jingmei Xiao, Ping Shao, et al.. (2022). PCSK9 mediates dyslipidemia induced by olanzapine treatment in schizophrenia patients. Psychopharmacology. 239(1). 83–91. 7 indexed citations
13.
Hei, Gangrui, Ye Yang, Yujun Long, et al.. (2022). Identifying and revealing different brain neural activities of cognitive subtypes in early course schizophrenia. Frontiers in Molecular Neuroscience. 15. 983995–983995. 6 indexed citations
14.
Hei, Gangrui, Ranran Li, Ye Yang, et al.. (2021). The Association Between Metabolic Disturbance and Cognitive Impairments in Early-Stage Schizophrenia. Frontiers in Human Neuroscience. 14. 599720–599720. 9 indexed citations
15.
Hei, Gangrui, Ye Yang, Chenchen Liu, et al.. (2021). The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia. Frontiers in Psychiatry. 12. 638773–638773. 8 indexed citations
16.
Wang, Xiaoyi, et al.. (2021). Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia. Neuroscience Bulletin. 37(11). 1609–1624. 39 indexed citations
17.
Yang, Ye, Yujun Long, Chenchen Liu, et al.. (2021). Effect of Bifidobacterium on olanzapine-induced body weight and appetite changes in patients with psychosis. Psychopharmacology. 238(9). 2449–2457. 23 indexed citations
18.
Xiao, Jingmei, Jing Huang, Yujun Long, et al.. (2021). Optimizing and Individualizing the Pharmacological Treatment of First-Episode Schizophrenic Patients: Study Protocol for a Multicenter Clinical Trial. Frontiers in Psychiatry. 12. 611070–611070. 11 indexed citations
19.
Huang, Jing, Gangrui Hei, Ye Yang, et al.. (2020). Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients. Frontiers in Pharmacology. 11. 739–739. 27 indexed citations
20.
Li, Ranran, Gangrui Hei, Li Li, et al.. (2018). Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials. Frontiers in Psychiatry. 9. 620–620. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026